| Code | CSB-RA022397MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is a research-grade biosimilar to NI-005, designed for research targeting superoxide dismutase 1 (SOD1). SOD1 is a crucial antioxidant enzyme that catalyzes the dismutation of superoxide radicals into oxygen and hydrogen peroxide, providing the first line of defense against oxidative stress in cells. This 32 kDa homodimeric protein is predominantly cytoplasmic and plays an essential role in maintaining cellular redox homeostasis. Mutations in the SOD1 gene are associated with approximately 20% of familial amyotrophic lateral sclerosis (ALS) cases, making it a critical target for neurodegenerative disease research. Both wild-type and mutant SOD1 proteins have been implicated in motor neuron toxicity through mechanisms including protein aggregation, mitochondrial dysfunction, and oxidative damage.
The reference antibody NI-005 has been utilized in research investigating SOD1 expression, localization, and pathological accumulation in neurodegenerative contexts. This biosimilar provides researchers with a reliable tool for studying SOD1 biology, exploring ALS pathogenesis mechanisms, evaluating potential therapeutic interventions, and investigating oxidative stress-related cellular processes across various experimental models.
There are currently no reviews for this product.